Swiss pharma company Roche is buying Flatiron Health for $1.9 billion

Roche, the global pharmaceutical company from Switzerland today announced it will scoop up Flatiron Health, a startup analyzing real-time oncology data to help cancer patients and doctors in a $1.9 billion deal. Flatiron has also confirmed the deal in a tweet. We are excited to announce that @FlatironHealth is being acquired by @Roche. By coming together with Roche, Flatiron will have an… Read More